# EDGAR Filing Document

**Accession Number:** 0001145986
**File Stem:** 0001171843-26-001072
**Filing Date:** 2026-2
**Character Count:** 35233
**Document Hash:** 2297119bfdbe70fd282ede53cfaf9318
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-26-001072.hdr.sgml**: 20260225

**ACCESSION NUMBER**: 0001171843-26-001072

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260225

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260225

**DATE AS OF CHANGE**: 20260225

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ASPEN AEROGELS INC
- **CENTRAL INDEX KEY:** 0001145986
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS [5030]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 043559972
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36481
- **FILM NUMBER:** 26674108

**BUSINESS ADDRESS:**
- **STREET 1:** 30 FORBES ROAD
- **STREET 2:** BUILDING B
- **CITY:** NORTHBOROUGH
- **STATE:** MA
- **ZIP:** 01532
- **BUSINESS PHONE:** 5086911111

**MAIL ADDRESS:**
- **STREET 1:** 30 FORBES ROAD
- **STREET 2:** BUILDING B
- **CITY:** NORTHBOROUGH
- **STATE:** MA
- **ZIP:** 01532

?xml version='1.0' encoding='ASCII'? Form 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

### Washington, D.C. 20549
_________________

### FORM 8-K
_________________

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): February 25, 2026
_______________________________

### ASPEN AEROGELS, INC.

#### (Exact name of registrant as specified in its charter)
_______________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-36481** | **04-3559972** |
| **(State or Other Jurisdiction of Incorporation)** | **(Commission File Number)** | **(I.R.S. Employer Identification No.)** |

---

---

| | |
|:---|:---|
| **30 Forbes Road, Building B<br>Northborough, Massachusetts** | **01532** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

#### Registrant's Telephone Number, Including Area Code: (508) 691-1111

#### (Former name or former address, if changed since last report)
_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

#### Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock | ASPN | The New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02. Results of Operations and Financial Condition.**

On February 25, 2026, Aspen Aerogels, Inc. announced its financial results for the fourth quarter and fiscal year 2025, which ended December 31, 2025, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1.

The information set forth in the press release, except for the information set forth under the headings "Financial Outlook" and "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.

**Item 7.01. Regulation FD Disclosure.**

The information set forth under the headings "Financial Outlook" and "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **<u>Exhibit Number</u>** | **<u>Description</u>** |
| [99.1](exh_991.htm) | [Press Release issued by Aspen Aerogels, Inc. on February 25, 2026](exh_991.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K.

The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | ASPEN AEROGELS, INC. | ASPEN AEROGELS, INC. |
| Date: February 25, 2026 | By: | <u>/s/ Grant Thoele&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
|  | Name: | Grant Thoele |
|  | Title: | Chief Financial Officer and Treasurer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

**Aspen Aerogels, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights**

*$158.6 million year-end cash balance; $37.6 million GM commercial settlement payment expected in Q1 2026*

*North Sea subsea pipeline award and continued European OEM program progress*

*Initiated a strategic review to strengthen long-term competitive positioning*

NORTHBOROUGH, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced financial results for the fourth quarter and full year 2025 and discussed recent business developments.

**Fourth Quarter 2025 Results**

Total revenue for the fourth quarter of 2025 was $41.3 million, compared to $123.1 million in the prior year period. Thermal barrier segment revenue was $16.1 million, compared to $70.0 million in the prior year period, reflecting a significant reduction in customer demand following changes in regulatory frameworks and incentive programs. Energy Industrial segment revenue was $25.3 million, compared to $53.1 million in the prior year period.

Net loss was $72.9 million, compared to net income of $11.4 million in the prior year period. Results for the fourth quarter of 2025 included restructuring and demobilization costs, loss on disposal of property, plant and equipment, impairment charges, and accelerated depreciation related to reassessed capacity. Excluding these items, adjusted net loss was $27.7 million.

Net loss per share was $0.88, compared to a net income per share of $0.14 in the prior year period. Excluding the items described above, adjusted net loss per share was $0.34.

Adjusted EBITDA was $(18.0) million, compared to $22.7 million in the prior year period.

**Full Year 2025 Results**

Total revenue for the full year 2025 was $271.1 million, compared to $452.7 million in the prior year. Thermal barrier segment revenue was $168.9 million, compared to $306.8 million in the prior year, reflecting a significant reduction in customer demand following changes in regulatory frameworks and incentive programs. Energy Industrial segment revenue was $102.2 million, compared to $145.9 million in the prior year.

Net loss was $389.6 million, compared to a net income of $13.4 million in the prior year. Results for 2025 included a $291.2 million impairment charge related to the previously planned Statesboro Plant, as well as restructuring and demobilization costs, accelerated depreciation, and loss on disposal of property, plant and equipment. Excluding these items, adjusted net loss was $40.5 million.

Net loss per share was $4.73, compared to a net income per share of $0.17 in the prior year. Excluding the items described above, adjusted net loss per share was $0.49.

Adjusted EBITDA was $2.9 million, compared to $89.9 million in the prior year.

A reconciliation of GAAP financial results to non-GAAP financial results is provided in the financial schedules that are part of this press release. An explanation of these non-GAAP financial measures is also included below under the heading "Non-GAAP Financial Measures."

**Liquidity and Capital Resources**

* Ended the year with cash, cash equivalents, and restricted cash of $158.6 million, compared to $152.4 million at the end of the third quarter, reflecting disciplined cash management

* Generated $16.1 million of cash from operating activities in the fourth quarter of 2025, driven by working capital initiatives

* Expect to receive approximately $37.6 million in the first quarter of 2026 from General Motors related to a commercial settlement associated with prior EV capacity adjustments

* Executed a non-binding letter of intent for the sale of assets from the demobilized Statesboro, Georgia facility after receiving multiple offers and expect to complete the transaction during 2026

**Commercial Developments**

* Confirmed that the EV customer award announced in the fourth quarter of 2025 relates to Volvo Cars, expanding Aspen's European OEM relationships; anticipating additional awards in 2026

* Awarded a North Sea subsea pipeline project with expected delivery in the third quarter of 2026

**Strategic Review to Support Long-Term Value Creation**

Aspen has initiated a strategic review to evaluate opportunities to strengthen its long-term competitive position. As part of this review, the Company will assess a broad range of potential actions to ensure it is appropriately structured and positioned to execute its priorities and create shareholder value.

The Company has engaged Piper Sandler & Co. as its exclusive financial advisor to assist with the review.

"We have initiated a review to evaluate our commercial growth plans and to optimize our capital structure," said Don Young, President and CEO. "This review is being conducted from a position of financial strength and operational progress. Our focus is clear — to ensure the company's strategy, capital allocation, and asset base are aligned to maximize value creation."

There can be no assurance that this review will result in any transaction or other strategic action. The Company has not established a deadline or timetable for the completion of this review and does not intend to provide updates or to comment on developments related to this review until further disclosure is appropriate or required by law.

**Financial Outlook**

Aspen issues its financial outlook as follows:

* Q1 2026 revenue is expected to range between $35 million and $40 million

* Q1 2026 Net loss is expected to range between $20 million and $23 million

* Q1 2026 Net loss per share is expected to range between $0.24 and $0.28

* Q1 2026 Adjusted EBITDA is expected to range between $(10) million and $(13) million

* FY 2026 Capital Expenditures are expected to be less than $10 million

Grant Thoele, Chief Financial Officer and Treasurer, noted, "2025 was a transitional year for Aspen. North American EV production levels decreased in response to evolving regulatory frameworks and end-market demand, while Energy Industrial results were weighted toward maintenance activity, with fewer large project awards. In response, we reduced our fixed cost structure by more than $75 million. Through disciplined cash management, the expected proceeds from our signed GM agreement, and the planned monetization of Statesboro assets, we expect to further strengthen our balance sheet and increase our net cash position. This financial foundation supports our strategic review and enables optionality as we evaluate the best path to position Aspen for long-term growth."

Thoele added, "As we begin 2026, our outlook reflects continued softness in thermal barrier volumes as EV demand finds a floor at lower production levels. From this base, supported by project momentum in our Energy Industrial segment, we expect topline growth going forward, with improving profitability driven by our leaner cost structure and disciplined execution."

The Company's Q1 2026 outlook assumes depreciation and amortization of $5.0 million, stock-based compensation expense of $2.5 million, net interest expense of $2.5 million, and diluted weighted average shares outstanding of 82.7 million for the quarter.

A reconciliation of net loss to non-GAAP Adjusted EBITDA for the financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."

Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2026, including those related to supply chain disruptions, or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.

**Conference Call and Webcast Notification**

A conference call with Aspen management to discuss fourth quarter and full year 2025 results and recent business developments will be held Wednesday, February 25, 2026, at 8:30 a.m. EST. During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.

Shareholders and other interested parties may call +1 (404) 975-4839 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "539718" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, www.aerogel.com<u>.</u>

Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.

**Non-GAAP Financial Measures**

In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides additional financial metrics that are not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measures included in this press release are Adjusted EBITDA, adjusted net loss and adjusted net loss per share. Management uses these non-GAAP financial measures, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measures do not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.

Management believes that these non-GAAP financial measures reflect Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies.

The non-GAAP financial measures do not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net income (loss), adjusted net loss to net loss and adjusted net loss per share to net loss per share, in each case to the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly filed reports in their entirety and not rely on any single financial measure.

**About Aspen Aerogels, Inc.**

Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform® into additional high-value markets. Aspen is headquartered in Northborough, Mass. For more information, please visit www.aerogel.com.

**Special Note Regarding Forward-Looking and Cautionary Statements** This press release and any related discussion contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's financial outlook. These statements are not historical facts but rather are based on Aspen's current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen's financial outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook," "assumes," "targets," "opportunity," and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen's beliefs and expectations about capacity, revenue, revenue capacity, backlog, costs, expenses, profitability, cash flow, gross profit, gross margin, operating margin, net income (loss), Adjusted EBITDA, adjusted net loss, adjusted net loss per share and related increases, decreases, trends or timing, including with respect to Aspen's beliefs and expectations about the EV market and how it may enable a path to profitability; Aspen's target revenue capacity and gross margins; Aspen's expectations related to the strategic review process, including the completion of such a process as well as the timetable related to such process; Aspen's expectation to receive approximately $37.6 million in the first quarter of 2026 from General Motors related to a commercial settlement; Aspen's efforts to use of its external manufacturing facility to meet customer demand; current or future trends in the energy, energy infrastructure, chemical and refinery, LNG, sustainable building materials, EV thermal barrier, EV battery materials or other markets and the impact of these trends on Aspen's business; the strength, effectiveness, productivity, costs, profitability or other fundamentals of Aspen's business; beliefs about the role of Aspen's technology and opportunities in the EV market; beliefs about Aspen's ability to provide and deliver products and services to EV customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen's EV opportunities, including the EV thermal barrier business; and the performance and market acceptance of Aspen's products. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: inability to successfully complete a strategic review process in a timely manner and further strengthen the Company's long-term positioning; inability to execute Aspen's growth plan, the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing under the contracts with EV thermal barrier customers; Aspen's inability to create customer or market opportunities for its products; any disruption or inability to achieve expected capacity levels in any of its manufacturing or assembly facilities, including at its external manufacturing facility; any failure to enforce any of Aspen's patents; the general economic conditions and cyclical demands in the markets that Aspen serves; and the other risk factors discussed under the heading "Risk Factors" in Aspen's Annual Report on Form 10-K for the year ended December 31, 2025 to be filed with the Securities and Exchange Commission ("SEC") in February 2026, as well as any updates to those risk factors filed from time to time in Aspen's subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.

**Investor Relations Contacts**

Neal Baranosky

Phone: (508) 691-1111 x 8

nbaranosky@aerogel.com

Georg Venturatos / Patrick Hall

Gateway Group

Phone: (949) 574-3860

ASPN@gateway-grp.com

---

| | | |
|:---|:---|:---|
| **ASPEN AEROGELS, INC.**<br>**Condensed Consolidated Balance Sheets**<br>**(Unaudited and in thousands)** | **ASPEN AEROGELS, INC.**<br>**Condensed Consolidated Balance Sheets**<br>**(Unaudited and in thousands)** | **ASPEN AEROGELS, INC.**<br>**Condensed Consolidated Balance Sheets**<br>**(Unaudited and in thousands)** |
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
|  | **(In thousands)** | **(In thousands)** |
| **Assets** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $156857 | $220882 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 1713 | 394 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 35270 | 109104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 38249 | 47551 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 9964 | 31517 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 242053 | 409448 |
| Property, plant and equipment, net | 98400 | 459276 |
| Assets held for sale | 32712 |  |
| Operating lease right-of-use assets | 18014 | 20854 |
| Finance lease right-of-use assets | 6131 |  |
| Other long-term assets | 9369 | 5566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $406679 | $895144 |
| **Liabilities and Stockholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $13243 | $44361 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 12952 | 36495 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 1259 | 2199 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance obligation for sale and leaseback transactions | 4443 | 4028 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | 3245 | 3279 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease liabilities | 1768 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Long term debt - current portion | 25115 | 19750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 62025 | 110112 |
| Revolving line of credit | 14346 | 42131 |
| Long term debt | 65455 | 94961 |
| Finance obligation for sale and leaseback transactions long-term | 4953 | 10087 |
| Operating lease liabilities long-term | 21138 | 23148 |
| Finance lease liabilities long-term | 3244 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 171161 | 280439 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 235518 | 614705 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $406679 | $895144 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **ASPEN AEROGELS, INC.**<br>**Consolidated Statements of Operations**<br>**(Unaudited and in thousands, except share and per share data)** | **ASPEN AEROGELS, INC.**<br>**Consolidated Statements of Operations**<br>**(Unaudited and in thousands, except share and per share data)** | **ASPEN AEROGELS, INC.**<br>**Consolidated Statements of Operations**<br>**(Unaudited and in thousands, except share and per share data)** | **ASPEN AEROGELS, INC.**<br>**Consolidated Statements of Operations**<br>**(Unaudited and in thousands, except share and per share data)** | **ASPEN AEROGELS, INC.**<br>**Consolidated Statements of Operations**<br>**(Unaudited and in thousands, except share and per share data)** |
|  | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  | **(In thousands, except**<br>**share and per share data)** | **(In thousands, except**<br>**share and per share data)** | **(In thousands, except**<br>**share and per share data)** | **(In thousands, except**<br>**share and per share data)** |
| Revenue | $41339 | $123088 | $271103 | $452699 |
| Cost of revenue | 64268 | 75955 | 225105 | 269802 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit (loss) | (22929) | 47133 | 45998 | 182897 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 2795 | 4405 | 13416 | 18050 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 6315 | 8547 | 28200 | 35677 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 15372 | 18660 | 55774 | 71125 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and demobilization costs | 1214 |  | 17510 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal of property, plant and equipment | 18162 |  | 18162 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment | 3597 | 808 | 291164 | 3510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 47455 | 32420 | 424226 | 128362 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) from operations | (70384) | 14713 | (378228) | 54535 |
| Other income (expense) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, convertible note - related party |  |  |  | (7550) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income (expense), net | (2701) | (3526) | (10716) | (4409) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  |  |  | (27487) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income | 75 |  | 1786 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | (2626) | (3526) | (8930) | (39446) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before income tax expense | (73010) | 11187 | (387158) | 15089 |
| Income tax expense | 97 | 175 | (2394) | (1714) |
| Net income (loss) | $(72913) | $11362 | $(389552) | $13375 |
| Net income (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.88) | $0.14 | $(4.73) | $0.17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.88) | $0.14 | $(4.73) | $0.17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 82662189 | 80909486 | 82328484 | 77535121 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 82662189 | 82998580 | 82328484 | 80306690 |

---

 **Analysis of Cash Flow**

The following table summarizes our cash flows for the periods indicated.

---

| | | |
|:---|:---|:---|
|  | **Year Ended** | **Year Ended** |
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
|  | **(In thousands)** | **(In thousands)** |
| Net cash provided by (used in): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $32872 | $45549 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (37449) | (86262) |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing activities | (58129) | 122018 |
| Net decrease in cash | (62706) | 81305 |
| Cash, cash equivalents and restricted cash at beginning of period | 221276 | 139971 |
| Cash, cash equivalents and restricted cash at end of period | $158570 | $221276 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, <br>2025** | **June 30, <br>2025** | **September 30, <br>2025** | **December 31, <br>2025** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| Net cash provided by (used in): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating activities | $5632 | $(3930) | $15035 | $16135 |
| &nbsp;&nbsp;&nbsp;&nbsp;Investing activities | (12998) | (12885) | (9102) | (2464) |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing activities | (21477) | (7586) | (21533) | (7533) |
| Net (decrease) increase in cash | (28843) | (24401) | (15600) | 6138 |
| Cash, cash equivalents and restricted cash at beginning of period | 221276 | 192433 | 168032 | 152432 |
| Cash, cash equivalents and restricted cash at end of period | $192433 | $168032 | $152432 | $158570 |

---

 **Reconciliation of Non-GAAP Financial Measures**

The following tables present a reconciliation of the non-GAAP financial measures included in this press release to the most directly comparable GAAP measures:

**Reconciliation of Adjusted EBITDA to Net income (loss)**

We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.

For the three and twelve months ended December 31, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
|  | **(In thousands)** | **(In thousands)** | **(In thousands)** | **(In thousands)** |
| Net income (loss) | $(72913) | $11362 | $(389552) | $13375 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 28175 | 5433 | 45157 | 22526 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 1247 | 2548 | 9173 | 12855 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other (income) expense | 2626 | 3526 | 8930 | 11959 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  |  |  | 27487 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | (97) | (175) | 2394 | 1714 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and demobilization costs | 1214 |  | 17510 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal of property, plant and equipment | 18162 |  | 18162 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment | 3597 | - | 291164 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $(17989) | $22694 | $2938 | $89916 |

---

 **Other Information**

The following tables reconcile net income (loss) and net income (loss) per share to adjusted net income (loss) and adjusted net income (loss) per share for the three and twelve months ended December 31, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | **Amount** | **Per Share** | **Amount** | **Per Share** |
|  | **(In thousands)** | | **(In thousands)** | |
| Net income (loss) | $(72913) | $(0.88) | $11362 | $0.14 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and demobilization costs | 1214 | 0.01 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal of property, plant and equipment | 18162 | 0.22 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment | 3597 | 0.04 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Reassessed capacity - accelerated depreciation | 22216 | 0.27 |  | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted Net Income (Loss) | $(27724) | $(0.34) | $11362 | $0.14 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Twelve Months Ended** | **Twelve Months Ended** | **Twelve Months Ended** | **Twelve Months Ended** |
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | **Amount** | **Per Share** | **Amount** | **Per Share** |
|  | **(In thousands)** | | **(In thousands)** | |
| Net income (loss) | $(389552) | $(4.73) | $13375 | $0.17 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and demobilization costs | 17510 | 0.21 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal of property, plant and equipment | 18162 | 0.22 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment | 291164 | 3.54 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Reassessed capacity - accelerated depreciation | 22216 | 0.27 |  | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted Net Income (Loss) | $(40500) | $(0.49) | $13375 | $0.17 |

---

Financial Outlook for the three months ending March 31, 2026:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ending** | **Three Months Ending** |
|  | **March 31, 2026** | **March 31, 2026** |
|  | **Low** | **High** |
|  | **(In thousands)** | **(In thousands)** |
| Net loss | $(23000) | $(20000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5000 | 5000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 2500 | 2500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | 2500 | 2500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $(13000) | $(10000) |

---